Back

Watch Compare

Apyx Medical Corp

Data quality: 100%

APYX

Nasdaq Manufacturing Measuring & Analyzing Instruments

$3.97

▲ $0.16 (4.20%)

Mkt Cap: 166.06 M

Price

$3.97

Mkt Cap

166.06 M

Day Range

$3.82 — $4.01

52-Week Range

$0.83 — $4.50

Volume

112,727

Open $3.83

50D / 200D Avg

$3.73

6.31% above

50D / 200D Avg

$3.07

29.27% above

Quick Summary

Key Takeaways

Revenue grew 2.16% annually over 5 years — modest growth

Debt/Equity of 6.41 — high leverage

Negative free cash flow of -9.12 M

Revenue growth is accelerating — 1Y growth exceeds 5Y average by 7.70%

Capital efficient — spends only 2.11% of revenue on capex

Growth

Revenue Growth (5Y)

2.16%

Below sector avg (9.35%)

Revenue (1Y)9.86%

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Quality

Return on Equity

-171.15%

Below sector avg (-51.02%)

ROIC-10.83%

Net Margin-21.22%

Op. Margin-12.20%

Safety

Debt / Equity

6.41

Above sector avg (0.33)

Current Ratio4.44

Interest Coverage-1.15

Valuation

PE (TTM)

-14.81

Below sector avg (-1.98)

P/B Ratio28.40

EV/EBITDAN/A

Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)

Metric	Stock	Sector Median
P/E	-14.8	-2.0
P/B	28.4	5.1
ROE %	-171.2	-51.0
Net Margin %	-21.2	-150.2
Rev Growth 5Y %	2.2	9.3
D/E	6.4	0.3

All Fundamental Metrics

Growth
Revenue Growth (1Y)	9.86%	Revenue Growth (3Y)	0.47%
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	2.16%	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	52.84 M	Net Income (TTM)	-11.21 M
ROE	-171.15%	ROA	-19.40%
Gross Margin	62.53%	Operating Margin	-12.20%
Net Margin	-21.22%	Free Cash Flow (TTM)	-9.12 M
ROIC	-10.83%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	6.41	Current Ratio	4.44
Interest Coverage	-1.15	Asset Turnover	0.91
Working Capital	37.81 M	Tangible Book Value	5.85 M
Dividends
Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	-14.81	Forward P/E	N/A
P/B Ratio	28.40	P/S Ratio	3.14
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	-5.49%
Market Cap	166.06 M	Enterprise Value	178.43 M
Per Share
EPS (Diluted TTM)	N/A	Revenue / Share	1.26
FCF / Share	-0.22	OCF / Share	-0.19
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A
Efficiency
CapEx / Revenue	2.11%	FCF Conversion	81.30%
SBC-Adj. FCF	-11.61 M	Growth Momentum	7.70

Income Statement

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	52.84 M	48.10 M	52.35 M	44.51 M	48.52 M
Net Income	-11.21 M	-23.46 M	-18.71 M	-23.18 M	-15.17 M
EPS (Diluted)	—	—	-0.54	-0.67	-0.44
Gross Profit	33.04 M	29.36 M	33.76 M	29.13 M	33.60 M
Operating Income	-6.45 M	-18.85 M	-17.26 M	-23.56 M	-14.45 M
EBITDA	—	—	—	—	—
R&D Expenses	3.37 M	5.08 M	4.84 M	4.54 M	4.32 M
SG&A Expenses	15.80 M	18.86 M	22.20 M	20.48 M	18.62 M
D&A	655,000.0	599,000.0	692,000.0	890,000.0	903,000.0
Interest Expense	5.59 M	5.91 M	2.48 M	15,000.0	10,000.0
Income Tax	270,000.0	252,000.0	-2.43 M	367,000.0	380,000.0

Balance Sheet

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	66.84 M	64.84 M	79.24 M	51.78 M	68.72 M
Total Liabilities	52.01 M	50.51 M	52.32 M	13.98 M	14.71 M
Shareholders' Equity	14.54 M	14.21 M	26.70 M	37.58 M	53.70 M
Total Debt	37.50 M	37.50 M	33.19 M	—	—
Cash & Equivalents	31.74 M	31.74 M	43.65 M	10.19 M	30.87 M
Current Assets	58.47 M	56.44 M	70.36 M	42.97 M	60.74 M
Current Liabilities	11.70 M	10.72 M	12.74 M	11.85 M	13.21 M